Spontaneous base flipping helps drive Nsp15’s preferences in double stranded RNA substrates.

Publication date: Jan 04, 2025

Coronaviruses evade detection by the host immune system with the help of the endoribonuclease Nsp15, which regulates levels of viral double stranded RNA by cleaving 3′ of uridine (U). While prior structural data shows that to cleave double stranded RNA, Nsp15’s target U must be flipped out of the helix, it is not yet understood whether Nsp15 initiates flipping or captures spontaneously flipped bases. We address this gap by designing fluorinated double stranded RNA substrates that allow us to directly relate a U’s sequence context to both its tendency to spontaneously flip and its susceptibility to cleavage by Nsp15. Through a combination of nuclease assays, F NMR spectroscopy, mass spectrometry, and single particle cryo-EM, we determine that Nsp15 acts most efficiently on unpaired Us, particularly those that are already flipped. Across sequence contexts, we find Nsp15’s cleavage efficiency to be directly related to that U’s tendency to spontaneously flip. Overall, our findings unify previous characterizations of Nsp15’s cleavage preferences, and suggest that activity of Nsp15 during infection is partially driven by bulged or otherwise relatively accessible Us that appear at strategic positions in the viral RNA.

Open Access PDF

Concepts Keywords
Coronaviruses Cleavage
Efficiency Double
Host Flip
Nsp15 Flipped
Spectrometry Flipping
Nsp15
Preferences
Rna
Sequence
Spontaneous
Stranded
Substrates
Tendency
Viral

Semantics

Type Source Name
disease IDO host
pathway REACTOME Immune System
drug DRUGBANK Uridine
disease IDO susceptibility
disease MESH infection
disease IDO replication
pathway KEGG Viral replication
disease MESH viral infection
disease MESH tumor
drug DRUGBANK Phosphate ion
disease IDO site
drug DRUGBANK Coenzyme M
disease MESH Hepatitis
drug DRUGBANK Fluorescein
drug DRUGBANK Pentaerythritol tetranitrate
drug DRUGBANK Albendazole
disease IDO assay
pathway REACTOME Digestion
drug DRUGBANK L-Alanine
drug DRUGBANK Titanium
disease IDO nucleic acid
drug DRUGBANK Adenosine
drug DRUGBANK Glutamic Acid
drug DRUGBANK Uracil
drug DRUGBANK Propylthiouracil
drug DRUGBANK N-Cyclohexyltaurine
drug DRUGBANK Thrombin
disease MESH ampicillin resistance
drug DRUGBANK Ampicillin
drug DRUGBANK Isopropyl beta-D-thiogalactopyranoside
drug DRUGBANK Tromethamine
drug DRUGBANK Glycerin
drug DRUGBANK Imidazole
drug DRUGBANK Edetic Acid
drug DRUGBANK Acetic acid
drug DRUGBANK Water
drug DRUGBANK Microcrystalline cellulose
disease IDO protein
drug DRUGBANK Urea
drug DRUGBANK Aspartame
drug DRUGBANK Gold
drug DRUGBANK Nitrogen
drug DRUGBANK Tricyclazole
drug DRUGBANK Flunarizine
drug DRUGBANK Medroxyprogesterone acetate
drug DRUGBANK Esomeprazole
drug DRUGBANK Trestolone
drug DRUGBANK Amber
drug DRUGBANK L-Aspartic Acid
drug DRUGBANK Tipiracil
drug DRUGBANK Guanosine
disease IDO cell
drug DRUGBANK Thymine
disease MESH Allergy
disease MESH Infectious Diseases
drug DRUGBANK Ademetionine
drug DRUGBANK Efavirenz
pathway REACTOME Reproduction

Original Article

(Visited 1 times, 1 visits today)